Naoto Kubota

9PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 04, 2026
VEGF-Positive Mass-Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis.

Junya Tsuzaki, Naoto Kubota, Shigeyoshi Soga

|Mar 02, 2026
Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass-Forming Intrahepatic Cholangiocarcinoma.

Naoto Kubota, Ken Yamazaki, Yasuhito Arai

|Feb 01, 2026
Gross Intrahepatic Mass Formation Predicts the Primary Site of Perihilar Cholangiocarcinoma Based on Molecular Pathologic Studies.

Yuki Masuda, Naoto Kubota, Ryo Takemura

|Dec 30, 2025
High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma.

Makoto Abe, Naoto Kubota, Ken Yamazaki

|Jun 10, 2023
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making.

Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre

|Apr 18, 2023
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.

Ilgen Mender, Silvia Siteni, Summer Barron

Pageof 2

Frequent Collaborators

4 joint publications

Yujin Hoshida

3 joint publications

Hidenori Ojima

2 joint publications

Naoto Fujiwara

1 joint publications

Cesia A Marquez